Urethral catheter-related urinary infection in critical patients admitted to the ICU. Descriptive data of the ENVIN-UCI study

Medicina intensiva
F Alvarez-LermaGrupo de Investigadores del Estudio Nacional de Vigilancia de Infección Nosocomial en UCI

Abstract

To describe trends in national catheter-related urinary tract infection (CRUTI) rates, as well as etiologies and multiresistance markers. An observational, prospective, multicenter voluntary participation study was conducted from 1 April to 30 June in the period between 2005 and 2010. Intensive Care Units (ICUs) that participated in the ENVIN-ICU registry during the study period. We included all patients admitted to the participating ICUs and patients with urinary catheter placement for more than 24 hours (78,863 patients). Patient monitoring was continued until discharge from the ICU or up to 60 days. CRUTIs were defined according to the CDC system, and frequency is expressed as incidence density (ID) in relation to the number of urinary catheter-patients days. A total of 2329 patients (2.95%) developed one or more CRUTI. The ID decreased from 6.69 to 4.18 episodes per 1000 days of urinary catheter between 2005 and 2010 (p<0.001). In relation to the underlying etiology, gramnegative bacilli predominated (55.6 to 61.6%), followed by fungi (18.7 to 25.2%) and grampositive cocci (17.1 to 25.9%). In 2010, ciprofloxacin-resistant E. coli strains (37.1%) increased, as well as imipenem-resistant (36.4%) and ciprofloxacin-resistant (3...Continue Reading

References

Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Mar 29, 2003·Intensive Care Medicine·Mitchell M LevyUNKNOWN International Sepsis Definitions Conference
Sep 4, 2004·Microbes and Infection·Marc LeoneClaude Martin
May 17, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·G KahlmeterO Stetsiouk
Jun 1, 2006·The American Journal of Medicine·John E McGowan
Sep 4, 2008·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Luis E CuellarLuis I Castillo-Bravo
Jan 22, 2009·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Diana ParkerMikel Gray
Mar 17, 2009·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Margaret WillsonMikel Gray
Jun 11, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Didier PittetUNKNOWN World Health Organization World Alliance for Patient Safety First Global Patient Safety Challenge Core Group of Experts
Dec 17, 2009·American Journal of Infection Control·Jonathan R EdwardsTeresa C Horan

❮ Previous
Next ❯

Citations

Feb 14, 2018·Informatics for Health & Social Care·Fadi Thabtah
Jun 12, 2020·Annals of the American Thoracic Society·Fernando G ZampieriUNKNOWN BRICNet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.